Free Trial

Benitec Biopharma (BNTC) SEC Filings & 10K Form

Benitec Biopharma logo
$13.68 +0.41 (+3.09%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$13.71 +0.03 (+0.22%)
As of 04/15/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Benitec Biopharma SEC Filings

DateFilerForm TypeView
04/02/2025
3:37 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
3:50 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13D/A
03/28/2025
3:51 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
4:10 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
9:53 AM
Benitec Biopharma (Filer)
Form 424B5
03/26/2025
7:13 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
4:25 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
6:18 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
3:43 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
1:20 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
11:37 AM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:19 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
6:51 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
3:15 PM
Benitec Biopharma (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SCHEDULE 13G/A
01/27/2025
11:51 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
01/03/2025
4:39 PM
Benitec Biopharma (Issuer)
Mukadam Sophie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/31/2024
5:34 AM
Benitec Biopharma (Filer)
Form 8-K/A
12/26/2024
3:28 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:48 PM
Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:17 PM
Benitec Biopharma (Issuer)
Boston Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:19 PM
Banks Jerel A. (Reporting)
Benitec Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:20 PM
Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:22 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:24 PM
Benitec Biopharma (Issuer)
Francis Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:01 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
12:47 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
12/05/2024
3:36 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:36 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
11/14/2024
3:53 PM
Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:32 PM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
11/07/2024
11:30 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
11/06/2024
2:26 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/01/2024
4:04 PM
Benitec Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/25/2024
1:19 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
10/23/2024
8:23 AM
Benitec Biopharma (Filer)
Form DEF 14A
10/22/2024
4:24 PM
Benitec Biopharma (Filer)
Form DEFA14A
10/15/2024
7:07 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
5:08 AM
Benitec Biopharma (Filer)
Form 424B5
10/11/2024
4:13 PM
Benitec Biopharma (Filer)
Form 424B5
Musk's panic move: What the world's richest man fears is coming (Ad)

Whether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determine whether you end up on the right or wrong side of financial history. The countdown has begun. There's still time to prepare, but that window narrows each day.

Click here to see what's coming and what you must do before it's too late.
10/11/2024
3:52 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:53 PM
Benitec Biopharma (Filer)
Form PRE 14A
10/08/2024
3:45 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:46 PM
Benitec Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/30/2024
4:17 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:18 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
09/26/2024
3:30 PM
Benitec Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/26/2024
3:43 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:28 PM
Benitec Biopharma (Filer)
Form DEF 14A
07/19/2024
3:59 PM
Benitec Biopharma (Filer)
Form PRE 14A
07/15/2024
4:18 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
9:22 AM
Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2024
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
05/13/2024
7:01 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
7:05 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:27 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2024
10:44 AM
Benitec Biopharma (Subject)
Oliveira Steven Michael (Filed by)
Form SC 13G
04/18/2024
8:45 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:53 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:BNTC) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners